Reprogramming macrophages against cancer cells with monoclonal antibodies (2017)
Attributed to:
Preclinical efficacy of an antibody of the IgE class against a melanoma-associated antigen
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Type: Conference/Paper/Proceeding/Abstract
Volume: 40
Parent Publication: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
ISSN: 1107-3756